News for Healthier Living

ASCO 2026 - Oral Drug Proved Highly Effective Against Chemotherapy-Related Low Platelets in GI Cancer Trial

In a phase 2 trial, avatrombopag--an oral drug approved for thrombocytopenia in liver disease--improved platelet recovery in GI cancer patients on chemotherapy. Treatment goals were met by 65% of patients receiving avatrombopag vs. 17% receiving placebo.

May 21, 2026


May 22 2026

May 21 2026

May 20 2026

May 19 2026

May 18 2026

May 17 2026

May 16 2026

May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026